Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women (2025) Stübs F, Dietl A, Schulmeyer C, Behrens A, Seibold A, Brückner L, Schleicher O, et al. Journal article PD-L1-Expression in in primary and recurrent vulvar squamous cell cancer (2025) Stübs F, Knöll A, Hartmann A, Leikauf LS, Matek C, John N, Häberle L, et al. Journal article The WHO Classification of Renal Cell Tumours: Implications forPersonalised Treatment Decisions and Accurate Detection ofHereditary Renal Cell Carcinomas Neue WHO-Klassifikation der Nierenzelltumore – Implikationen für eine individuelle Therapieentscheidung und die adäquate Erkennung von erblichen Nierenzellkarzinomen (2025) Toma MI, Müller RU, Grünwald V, Hartmann A, Junker Kt Journal article, Review article Solitary fibrous tumor of kidney and renal hilus: a multi-institutional clinicopathologic analysis of 43 cases (2025) Güner G, Akgul M, Michal M, Yilmaz A, Bayrak BY, Hasbay B, Yazgan A, et al. Journal article PU.1 upregulation is linked to improved prognosis in non-small cell lung cancer (2025) Hohenberger K, Trufa D, Hartmann A, Mittler S, Trump S, Sirbu H, Finotto S Journal article Peniskarzinom: Die Bedeutung der histologischen Klassifikation und neue Behandlungsansätze (2025) Fiegl A, Mink JN, Junker K, Linxweiler J, Hartmann A Journal article, Review article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children (2025) Hironimus T, Degen S, Rappl A, Allabauer I, Wölfle J, Hartmann A, Bruns V, et al. Journal article Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer (2025) Gloßner L, Eckstein M, Mark C, Beckmann M, Hartmann A, Strissel P, Strick R Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article